Compare StocksJNJ vs STZ

Johnson & Johnson (JNJ) vs Constellation Brands, Inc. (STZ): Which Is the Better Buy in 2026?

As of 2026-06-19, JNJ is fairly valued at $228, with a DCF intrinsic value of $281 and a margin of safety of 19%. STZ is overvalued at $141, with an intrinsic value of $118 and a margin of safety of -20%. Of the two, JNJ has the wider margin of safety.

JNJ
Johnson & Johnson
$228.39
VS
STZ
Constellation Brands, Inc.
$141.18

Rewards

JNJ
  • Johnson & Johnson has maintained ROIC above 15% for 4 consecutive years, indicating a durable competitive advantage.
  • Gross margin of 68.0% indicates strong pricing power — typical of businesses with significant intellectual property or brand strength.
  • Johnson & Johnson scores 90/100 on the Economic Moat Score (Wide Moat), with revenue predictability as the strongest competitive dimension.
STZ
  • Constellation Brands, Inc. has maintained ROIC above 10% for 4 consecutive years, suggesting solid business economics.
  • Constellation Brands, Inc. scores 78/100 on the Economic Moat Score (Wide Moat), with margin stability as the strongest competitive dimension.
  • Each dollar of retained earnings has created $15.86 of earning power — management is an exceptional capital allocator.

Risks

JNJ
  • Trailing P/E of 26.5x is 33% above the historical average of 20.0x — the stock trades at a premium to its own history.
  • PEG ratio of 3.06 indicates the stock is expensive relative to its expected growth — the market may be pricing in more growth than analysts project.
  • Insiders have sold $2.4M worth of stock in the past 3 months — significant insider liquidation.
STZ
  • PEG ratio of 2.67 indicates the stock is expensive relative to its expected growth — the market may be pricing in more growth than analysts project.

Key Valuation Metrics

Learn more →
JNJ
STZ
Valuation
$19.31B
Free Cash Flow
$2.05B
3.51%
FCF Yield
8.46%
26.46
Trailing P/E
14.69
17.96
Forward P/E
11.38
Quality & Moat
15.32%
ROIC
9.83%
26.42%
ROE
22.64%
68.04%
Gross Margin
51.65%
3.06
PEG Ratio
2.67
Balance Sheet Safety
0.41
Net Debt / Equity
1.32
N/A
Interest Coverage
N/A
0.96
Net Debt / EBITDA
3.28
2.22%
Dividend Yield
2.86%
JNJ: 6Ties: 1STZ: 5
JNJSTZ

Historical Fundamentals

Learn more →
JNJ

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

STZ

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

$1 Retained Earnings Test

Learn more →
JNJ
$0.91
created per $1 retained over 3 years
Mediocre Allocator
Σ Retained
$40.05B
Δ Market Cap
+$36.63B
Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer
STZ
$-16.16
created per $1 retained over 3 years
Market Cap Declined
Σ Retained
$1.23B
Δ Market Cap
$-19.90B
Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

Discounted Cash Flow (DCF) Analysis

Learn more →
JNJ
18.6% Margin of Safety
Price is 18.6% below estimated fair value
Current Price: $228.39
Fair Value: $280.51
Strongly undervalued
Undervalued
Fairly valued
Overvalued
Strongly overvalued
STZ
20.1% Overvalued
Price is 20.1% above estimated fair value
Current Price: $141.18
Fair Value: $117.54
Strongly undervalued
Undervalued
Fairly valued
Overvalued
Strongly overvalued

Reverse DCF — Market-Implied Growth

Learn more →
JNJ

What growth rate is the market pricing in at $228?

+7.7%
Market-Implied Owner Earnings Growth
Standard FCF implies +13.3%

The market implies +7.7% Owner Earnings growth, above historical trends.

Standard FCF implies a demanding +13.3%, reflecting heavy growth investment.

STZ

What growth rate is the market pricing in at $141?

+8.3%
Market-Implied Owner Earnings Growth
Standard FCF implies +5.7%

Economic Moat Score

Learn more →
JNJ
90/100
Wide Moat
70+ Wide · 40-69 Narrow · <40 None

Wide moat with strength across all dimensions. Revenue Predictability is the standout factor.

Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 5 years of fundamental data.
STZ
78/100
Wide Moat
70+ Wide · 40-69 Narrow · <40 None

Wide moat driven primarily by margin stability. Reinvestment Efficiency is the area most vulnerable to competitive pressure.

Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 4 years of fundamental data.

Forensic Accounting

Learn more →
JNJ
-2.31
Unlikely Manipulator
Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

M-Score Trend

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.
STZ

Insufficient data for Beneish M-Score calculation (requires 2+ years).

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

Ownership Breakdown

Learn more →
JNJ
Insiders 0.1%Institutions 76.9%Retail & Other 23.1%
No. of Institutional Holders5,728
High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.
STZ
Insiders 12.9%Institutions 88.2%
No. of Institutional Holders1,430
High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.

High insider ownership aligns management incentives with shareholders. Institutional concentration can indicate smart-money conviction but also crowding risk.

Insider Buying Activity

Learn more →
JNJ
0
Buys (3M)
1
Buys (12M)
Total value (12M): $257,688
MORIKIS JOHN G
Director
$257,688
@ $206.15 · 2025-11-26
WEINBERGER MARK A
Director
$147,220
@ $147.22 · 2024-12-12
Open market purchases · includes direct & indirect ownership · excludes option exercises
STZ
0
Buys (3M)
1
Buys (12M)
Total value (12M): $340,886
BALDWIN CHRISTOPHER J.
Director
$340,886
@ $170.44 · 2025-07-08
GILES WILLIAM T
Director
$186,390
@ $186.39 · 2025-01-17
Open market purchases · includes direct & indirect ownership · excludes option exercises

Open market purchases · includes direct & indirect ownership · excludes option exercises.

Insider Selling Activity

Learn more →
JNJ
1
Sells (3M)
13
Sells (12M)
Total value (12M): $103.65M
WENGEL KATHRYN E
Chief Technology Officer
$2.41M
@ $241.15 · 2026-06-11
DECKER ROBERT J
Officer
$1.01M
@ $247.87 · 2026-02-27
SCHMID TIMOTHY
Officer
$324,763
@ $245.66 · 2026-02-20
SCHMID TIMOTHY
Officer
$5.53M
@ $244.33 · 2026-02-18
SWANSON JAMES D
Chief Technology Officer
$15.11M
@ $243.39 · 2026-02-17
BROADHURST VANESSA
Officer
$1.51M
@ $243.39 · 2026-02-17
WOLK JOSEPH J
Chief Financial Officer
$21.77M
@ $242.80 · 2026-02-17
REED JOHN C
Officer
$13.11M
@ $243.00 · 2026-02-17
REED JOHN C
Officer
$4.19M
@ $192.71 · 2025-10-17
TAUBERT JENNIFER L
Officer
$10.04M
@ $177.81 · 2025-09-04
DUATO JOAQUIN BOIX
Chief Executive Officer
$22.55M
@ $179.21 · 2025-08-22
WOLK JOSEPH J
Chief Financial Officer
$2.98M
@ $176.91 · 2025-08-15
REED JOHN C
Officer
$3.13M
@ $163.55 · 2025-07-17
DECKER ROBERT J
Officer
$1.16M
@ $165.88 · 2025-02-25
SCHMID TIMOTHY
Officer
$62,928
@ $156.15 · 2025-02-18
WOLK JOSEPH J
Chief Financial Officer
$2.00M
@ $153.89 · 2025-02-07
DECKER ROBERT J
Officer
$930,113
@ $165.06 · 2024-08-30
Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives
STZ
2
Sells (3M)
4
Sells (12M)
Total value (12M): $1.16M
BOURDEAU JAMES O
Officer
$631,259
@ $143.24 · 2026-05-12
HERNANDEZ ERNESTO M.
Director
$307,830
@ $153.91 · 2026-04-27
GLAETZER SAMUEL J
Officer
$85,345
@ $153.77 · 2026-02-17
BOURDEAU JAMES O
Officer
$138,749
@ $169.00 · 2025-07-21
GLAETZER SAMUEL J
Officer
$593,901
@ $188.54 · 2025-05-13
SER BUSINESS HOLDINGS LP
Beneficial Owner of more than 10% of a Class of Security
$159,060
@ $241.00 · 2024-11-20
SABIA JAMES ANTHONY JR.
President
$8.77M
@ $242.99 · 2024-11-14
NEWLANDS WILLIAM A
Chief Executive Officer
$6.09M
@ $243.58 · 2024-11-14
CAREY KANEENAT KRISTANN
Officer
$78,870
@ $239.00 · 2024-11-13
NEWLANDS WILLIAM A
Chief Executive Officer
$1.76M
@ $237.24 · 2024-10-29
GLAETZER SAMUEL J
Officer
$370,809
@ $245.57 · 2024-10-14
HANKINSON GARTH
Chief Financial Officer
$8.09M
@ $240.10 · 2024-08-09
MCCARTHY DANIEL J
Director
$468,009
@ $252.43 · 2024-07-26
CAREY KANEENAT KRISTANN
Officer
$254,997
@ $261.00 · 2024-07-12
Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives

Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives.

🎭 Mr. Market's Mood

Learn more →
JNJ
FearGreed
😏Greed(62/100)

"Market is optimistic — be cautious and ensure you have a margin of safety"

Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.
STZ
FearGreed
😐Neutral(45/100)

"Market is pricing this stock without strong emotion in either direction"

Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

Composite sentiment score based on market signals. Inspired by Buffett’s "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

⚖️ Buffett Signal

Learn more →
JNJ
Awaiting DCF Data

The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

DCF Margin of Safety: N/AMr. Market's Mood: Greed (62)
STZ
Awaiting DCF Data

The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

DCF Margin of Safety: N/AMr. Market's Mood: Neutral (45)
View JNJ Full AnalysisView STZ Full Analysis

Frequently Asked Questions: JNJ vs STZ

Is Johnson & Johnson or Constellation Brands, Inc. more undervalued in 2026?

Based on our discounted cash flow model, JNJ trades at a 18.6% margin of safety (intrinsic value $281 vs. price $228), compared to STZ's -20.1% margin of safety (intrinsic $118 vs. $141).

Which stock has a wider economic moat, Johnson & Johnson or Constellation Brands, Inc.?

JNJ scores 90/100 (Wide moat), while STZ scores 78/100 (Wide moat). The moat score measures competitive advantage durability across ROIC consistency, margin stability, revenue predictability, and reinvestment efficiency.

Is Constellation Brands, Inc. in financial distress?

STZ's Altman Z-Score of 2.8 places it in the Grey zone, signaling elevated bankruptcy risk. JNJ scores 3.5 (Safe zone). The Altman Z-Score is a five-factor model that predicts insolvency within two years; scores below 1.81 indicate significant distress.

Which company has better free cash flow, Johnson & Johnson or Constellation Brands, Inc.?

Constellation Brands, Inc. (STZ) generates a 8.5% free cash flow yield, compared to Johnson & Johnson's 3.5%. A higher FCF yield means the business converts more of its market value into cash that can be returned to shareholders or reinvested.

Which stock has higher return on invested capital, Johnson & Johnson or Constellation Brands, Inc.?

JNJ earns 15.3% ROIC versus STZ's 9.8%. A higher ROIC means the company generates more profit per dollar of capital employed, a hallmark of durable competitive advantage in Buffett-style analysis.

Which dividend is safer, Johnson & Johnson's or Constellation Brands, Inc.'s?

STZ's dividend earns a safety score of 94/100 (Very Safe), compared to JNJ's 79/100 (Safe). STZ has raised its dividend for 3 consecutive years.